Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


12 Nov 2016 - 16 Nov 2016
16 Nov 2016 - 19 Nov 2016

Zeiss to Acquire Xradia to Expand its Microscopy Market

By BiotechDaily International staff writers
Posted on 24 Jun 2013
Print article
Zeiss (Oberkochen, Germany), an international leader of optics and optoelectronics systems recently reported on the acquisition of Xradia, Inc. (Pleasanton, CA, USA), which is expected to expand the company from light and electron microscopy into X-ray microscopy technology.

Xradia is a medium-size company that developed innovative three-dimensional (3D) X-ray microscopes for academic and industrial research purposes.

Xradia, Inc., after closing the deal, will operate under the new name Carl Zeiss X-ray Microscopy, Inc.

Related Links:

Print article


Drug Discovery

view channel
Image: Positive alpha-synuclein staining of a Lewy body from a patient with Parkinson\'s disease (Photo courtesy of Wikimedia Commons).

Bifunctional Dimer Drugs Prove Effective in Parkinson's Disease Yeast Model

A team of Canadian neurodegenerative disease researchers used a yeast model system to identify novel drug compounds that were able to block the misfolding of alpha- synuclein (AS) protein, which characterizes... Read more


view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.